COVIR (CVR ) = 💰💰 Start investing now 💰💰steemCreated with Sketch.

in #covir4 years ago (edited)

image.png

Crypto Asset Investment easily and safely.
Start investing now

We are delighted to announce the premium token offering of COVIR (CVR) coming soon. The details are listed below - Happy trading!

Subscription time:
Round 1 : 2020/07/31 17:00 (GMT+8) - 2020/08/07 17:00 (GMT+8)
Round 2 : 2020/08/10 17:00 (GMT+8) - 2020/08/14 17:00 (GMT+8)

Trading Time:
CVR/BTC, CVR/USDT trading will open on 2020/08/27 17:00 (GMT+8)
CVR deposit and withdrawal will open on 2020/09/03 17:00 (GMT+8)
Subscription Rules:

Total Supply: 400,000,000 CVR
Circulating Supply: 0 CVR
Subscription Amount (on BitForex):
Round 1: 3,750,000 CVR
Round 2: 3,750,000 CVR
Subscription Price: 0.2 USDT
Subscription Trading Mode: CVR/BTC
Bonus (based on the subscription amount):
15% CVR bonus for top 50 buyers (for both rounds)
10% CVR bonus for all rest subscribers (for both rounds)
Bonus will be distributed in 7 business days after the end of Subscription by BitForex
The subscription will stop when reaching the hard cap or reaching the end time. First come first served.
During the CVR subscription stage, users can only buy CVR at a fixed price.

image.png

Token Info
Project Name: COVIR
Token Symbol: CVR
Official Website: https://covir.io
Blockchain Explorer: https://tzstats.com/
Whitepaper: https://covir.fr/wp-content/uploads/2020/03/covir_v2-2.pdf
Covir is the exclusive partner of Octopus Robots for the funding of robotic disinfection systems international licenses based on tezos blockchain.

In partnership with COVIR.IO, operational pre-financing vehicle, Octopus Robots launches the pre-financing of its global portfolio of potential licenses by TOKENIZING ITS LICENSING RIGHTS ON THE TEZOS BLOCKCHAIN.

The digitalization of License rights, intangible assets, thanks to the tokenization, will allow better liquidity, pooling, and opening to all the countries or geographical areas. The blockchain technology helps to gain efficiency, thanks to COVIR.IO smart contract automating the sale of the token and the distribution of the royalties.

image.png

Important Subscription Notice:
KYC is required for CVR token sale;
The minimum order amount for a single account: 100 CVR = 20 USD
The maximum order amount for a single account: 1,000,000 CVR = 200,000 USD
According to relevant regulations, users from the following countries/regions (according to KYC information) cannot participate in the subscription: United States.

image.png

Conclusion
The current pandemic has changed our life style besides the economic sector is also very affected by this, On the other hand the Blockchain sector received a fairly positive response where some processes have used Blockchain technology. Covir & Octopusrobots is one of them by offering a token license based on tezos technology where holders will receive royalties later. With the combination of Blockchain technology and also automation technology offered, they may become an alternative solution that will reduce the level of Covid-19 deployment by accelerating Octopus Biosafety robot realization in every place and of course become one of the inventors from a combination of these two technologies.

I think it's enough for now, Do not forget to follow & upvote for more content about new project, I will give some links related to Covir Project below. Thank you very much!

Website: https://covir.io
Telegram: https://t.me/covirio
Whitepaper: https://covir.fr/wp-content/uploads/2020/03/covir_v2-2.pdf
Twitter: https://twitter.com/Covir_io
Facebook: https://web.facebook.com/Covir-100486328352987?_rdc=1&_rd
LinkedIn: https://www.linkedin.com/company/covir-io/
YouTube: https://www.youtube.com/c/OCTOPUSROBOTS
BitcoinTalk Thread: https://bitcointalk.org/index.php?topic=5243195.msg54290230#msg54290230

Author: yusuf ganteng
Telegram : @yusufganteng
BitcoinTalk profile link : https://bitcointalk.org/index.php?action=profile;u=2076429
email : [email protected]

Coin Marketplace

STEEM 0.19
TRX 0.25
JST 0.037
BTC 96709.35
ETH 3340.46
USDT 1.00
SBD 3.16